053950 — Kyung Nam Pharm Co Cashflow Statement
0.000.00%
- KR₩65bn
- KR₩50bn
- KR₩56bn
Annual cashflow statement for Kyung Nam Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3,413 | -6,779 | -22,228 | 8,642 | -9,007 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1,492 | 4,470 | 16,410 | -6,939 | 7,950 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6,267 | 420 | 3,653 | -2,340 | -2,322 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9,342 | 71.6 | 693 | 1,838 | -1,682 |
| Capital Expenditures | -2,637 | -2,918 | -4,177 | -1,666 | -1,263 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,368 | -304 | -39,834 | 2,203 | -38,350 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,269 | -3,222 | -44,010 | 536 | -39,613 |
| Financing Cash Flow Items | -48.6 | -587 | 531 | -1,685 | 3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10,756 | 23,261 | 26,146 | 22,182 | -3,241 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 203 | 20,061 | -17,032 | 24,854 | -44,560 |